GoodRx Holdings
(NASDAQ:GDRX)
$6.505
0.075[1.17%]
Last update: 2:03PM Get Real Time Here

GET A REPORT ON GDRX SENT RIGHT TO YOUR INBOX

GoodRx Holdings Stock (NASDAQ:GDRX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Neutral
Highest Price Target1
$50.00
Lowest Price Target1
$4.50
Consensus Price Target1
$14.72

Analyst Rating Summary1

Analyst Ratings
Sep 23
1
Nov 23
4
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Truist Securities
B of A Securities
JP Morgan
Goldman Sachs

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for GoodRx Holdings

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
01/16/2024GDRXBuy Now
GoodRx Holdings
$6.389.72%RBC Capital
Sean Dodge
$5 → $7MaintainsSector PerformGet Alert
01/12/2024GDRXBuy Now
GoodRx Holdings
$6.3817.55%Truist Securities
Jailendra Singh
$5.5 → $7.5MaintainsHoldGet Alert
01/02/2024GDRXBuy Now
GoodRx Holdings
$6.38-29.47%B of A Securities
Michael Cherny
$8 → $4.5DowngradeBuy → UnderperformGet Alert
11/17/2023GDRXBuy Now
GoodRx Holdings
$6.38-5.96%JP Morgan
Doug Anmuth
$7 → $6MaintainsNeutralGet Alert
11/13/2023GDRXBuy Now
GoodRx Holdings
$6.38-5.96%Goldman Sachs
Eric Sheridan
$7 → $6MaintainsNeutralGet Alert
11/10/2023GDRXBuy Now
GoodRx Holdings
$6.38-21.63%RBC Capital
Sean Dodge
$8 → $5MaintainsSector PerformGet Alert
11/10/2023GDRXBuy Now
GoodRx Holdings
$6.38-5.96%Goldman Sachs
Eric Sheridan
$7 → $6MaintainsNeutralGet Alert
11/10/2023GDRXBuy Now
GoodRx Holdings
$6.38-13.79%Truist Securities
Jailendra Singh
$8 → $5.5MaintainsHoldGet Alert
11/10/2023GDRXBuy Now
GoodRx Holdings
$6.38-13.79%Morgan Stanley
Ricky Goldwasser
$8 → $5.5MaintainsEqual-WeightGet Alert
09/14/2023GDRXBuy Now
GoodRx Holdings
$6.389.72%JP Morgan
Doug Anmuth
$6 → $7MaintainsNeutralGet Alert
08/11/2023GDRXBuy Now
GoodRx Holdings
$6.389.72%Goldman Sachs
Eric Sheridan
$6.25 → $7MaintainsNeutralGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.3825.39%Deutsche Bank
George Hill
$6 → $8MaintainsHoldGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.3856.74%Guggenheim
Sandy Draper
$8 → $10MaintainsBuyGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.38-5.96%JP Morgan
Doug Anmuth
$5 → $6MaintainsNeutralGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.3872.41%Citigroup
Daniel Grosslight
$7 → $11MaintainsBuyGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.3856.74%Evercore ISI Group
Mark Mahaney
$7 → $10MaintainsIn-LineGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.389.72%Goldman Sachs
Eric Sheridan
$6.25 → $7MaintainsNeutralGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.3825.39%Credit Suisse
Jonathan Yong
$7 → $8MaintainsNeutralGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$6.3825.39%RBC Capital
Sean Dodge
$6 → $8MaintainsSector PerformGet Alert

FAQ

Q

What is the target price for GoodRx Holdings (GDRX)?

A

The latest price target for GoodRx Holdings (NASDAQ: GDRX) was reported by RBC Capital on January 16, 2024. The analyst firm set a price target for $7.00 expecting GDRX to rise to within 12 months (a possible 7.61% upside). 35 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for GoodRx Holdings (GDRX)?

A

The latest analyst rating for GoodRx Holdings (NASDAQ: GDRX) was provided by RBC Capital, and GoodRx Holdings maintained their sector perform rating.

Q

When is the next analyst rating going to be posted or updated for GoodRx Holdings (GDRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on January 16, 2024 so you should expect the next rating to be made available sometime around January 16, 2025.

Q

Is the Analyst Rating GoodRx Holdings (GDRX) correct?

A

While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $5.00 to $7.00. The current price GoodRx Holdings (GDRX) is trading at is $6.51, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch